Innoviva, Inc.(INVA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INVA Innoviva, Inc.

已收盘 10-09 16:00:00 EDT

21.21

+0.34

+1.63%

盘后21.21

+0.000.00%

19:38 EDT

最高21.28	最低20.78	成交量50.76万
今开20.80	昨收20.87	日振幅2.40%
总市值15.32亿	流通市值14.64亿	总股本7,225万
成交额1,073万	换手率0.74%	流通股本6,902万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"INVA","market":"US","secType":"STK","nameCN":"Innoviva, Inc.","latestPrice":21.21,"timestamp":1791576000000,"preClose":20.87,"halted":0,"volume":507566,"hourTrading":{"tag":"盘后","latestPrice":21.21,"preClose":21.21,"latestTime":"19:38 EDT","volume":33069,"amount":701383.84,"timestamp":1791589119727,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.016291327264015325,"floatShares":69021905,"shares":72245485,"eps":4.304385,"marketStatus":"已收盘","change":0.34,"latestTime":"10-09 16:00:00 EDT","open":20.8,"high":21.28,"low":20.78,"amount":10734767.117,"amplitude":0.023958,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.304385,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":20.87,"preHourTrading":{"tag":"盘前","latestPrice":21.05,"preClose":20.87,"latestTime":"09:25 EDT","volume":15,"amount":315.75,"timestamp":1791552300054,"change":0.18,"changeRate":0.008625,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":21.21,"preClose":21.21,"latestTime":"19:38 EDT","volume":33069,"amount":701383.84,"timestamp":1791589119727,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.686555,"impliedVol":0.5533,"impliedVolPercentile":0.8008},"requestUrl":"/m/hq/s/INVA","defaultTab":"news","newsList":[{"id":"1161509173","title":"Nortiva Bio正式成立，致力于开发长效口服药物","url":"https://stock-news.laohu8.com/highlight/detail?id=1161509173","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161509173?lang=zh_cn&edition=full","pubTime":"2026-06-18 21:14","pubTimestamp":1781788486,"startTime":"0","endTime":"0","summary":"Innoviva公司宣布成立新实体Nortiva Bio，该公司的核心使命是研发长效口服药物。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120163638","title":"Innoviva Specialty Therapeutics 与 Dr. Reddy's 就 Xacduro® 在特定国际市场达成分销及授权协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1120163638","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120163638?lang=zh_cn&edition=full","pubTime":"2026-06-16 20:04","pubTimestamp":1781611465,"startTime":"0","endTime":"0","summary":"Innoviva Specialty Therapeutics 宣布，已与 Dr. Reddy's Laboratories Ltd. 就抗菌药物 Xacduro在特定国际市场达成一项分销及授权协议。根据协议条款，Dr. Reddy's 将获得在协议涵盖区域内商业化 Xacduro 的独家权利。此次合作标志着 Innoviva 旗下专业治疗部门在拓展其产品全球影响力方面迈出了关键一步。Xacduro 此前已获得美国食品药品监督管理局批准，此次与国际知名制药公司 Dr. Reddy's 的合作，有望进一步优化其在选定国际市场的分销网络和商业化进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INVA","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124645166","title":"Innoviva达成协议 在特定国际市场扩大Xacduro用于鲍曼不动杆菌感染的可及性","url":"https://stock-news.laohu8.com/highlight/detail?id=1124645166","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124645166?lang=zh_cn&edition=full","pubTime":"2026-06-16 20:03","pubTimestamp":1781611409,"startTime":"0","endTime":"0","summary":"Innoviva公司宣布达成一项协议，将在选定的国际市场扩大其药物Xacduro用于治疗鲍曼不动杆菌感染的可及性。该协议旨在让更多患者能够获得这一针对特定细菌感染的药物。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","INVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517822467","title":"Innoviva(INVA.US)获Scotiabank首次覆盖，给予跑赢大盘评级, 目标价55.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517822467","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517822467?lang=zh_cn&edition=full","pubTime":"2025-03-08 06:57","pubTimestamp":1741388258,"startTime":"0","endTime":"0","summary":"Innoviva(INVA.US)获Scotiabank首次覆盖，给予跑赢大盘评级, 目标价55.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08065748605350.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["INVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101956474","title":"Innoviva第四季度每股收益$0.26未达预期$0.37，但销售额$91.81M超出预期$86.80M","url":"https://stock-news.laohu8.com/highlight/detail?id=1101956474","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101956474?lang=zh_cn&edition=full","pubTime":"2025-02-27 05:37","pubTimestamp":1740605828,"startTime":"0","endTime":"0","summary":"Innoviva公布其季度每股收益为$0.26，低于分析师普遍预期的$0.37，差距为29.73%。与去年同期每股收益$0.76相比下降了65.79%。公司报告其季度销售额为$91.81百万，超出分析师普遍预期的$86.80百万，超出预期5.77%。以上内容来自Benzinga Earnings专栏，原文如下：Innoviva  reported quarterly earnings of $0.26 per share which missed the analyst consensus estimate of $0.37 by 29.73 percent. This is a 65.79 percent decrease over earnings of $0.76 per share from the same period last year.  The company reported quarterly sales of $91.81 million which beat the analyst consensus estimate of $86.80 million by","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Innoviva第四季度每股收益$0.26未达预期$0.37，但销售额$91.81M超出预期$86.80M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483382235","title":"Innoviva, Inc.盘中异动 快速下跌5.20%报19.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483382235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483382235?lang=zh_cn&edition=full","pubTime":"2024-11-15 01:34","pubTimestamp":1731605654,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日01时34分，Innoviva, Inc.股票出现波动，股价快速下跌5.20%。截至发稿，该股报19.06美元/股，成交量27.4719万股，换手率0.44%，振幅3.33%。Innoviva, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。Innoviva, Inc.公司简介：Innoviva Inc 是一家拥有专利使用费和创新医疗保健资产组合的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115013414a2383b5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115013414a2383b5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2482208921","title":"Innoviva, Inc.盘中异动 快速拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482208921","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482208921?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:48","pubTimestamp":1731422888,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时48分，Innoviva, Inc.股票出现异动，股价大幅拉升5.07%。Innoviva, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Geovax Labs, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为139.43%、134.16%、61.61%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Heron Therapeutics, Inc.，振幅分别为49.39%、34.55%、26.63%。Innoviva, Inc.公司简介：Innoviva Inc 是一家拥有专利使用费和创新医疗保健资产组合的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112224808a230c679&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112224808a230c679&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","INVA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inva.com","stockEarnings":[{"period":"1week","weight":0.0156},{"period":"1month","weight":-0.022},{"period":"3month","weight":-0.0616},{"period":"6month","weight":-0.1216},{"period":"1year","weight":0.2015},{"period":"ytd","weight":0.044}],"compareEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":0.0104},{"period":"3month","weight":0.0251},{"period":"6month","weight":0.139},{"period":"1year","weight":0.1498},{"period":"ytd","weight":0.1349}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Innoviva, Inc.于1996年11月在特拉华州注册，名为高级医药股份有限公司。公司于1997年5月开始运营。公司于2006年1月7日将名字改为Innoviva，是一家生物制药公司，拥有一系列内部发现的候选产品以及与制药公司的战略合作。公司集中于小分子药物的发现、开发和销售，用于诸多医疗领域，包括呼吸疾病、细菌感染、中枢神经系统疾病。其战略集中于发现、开发、销售高效的、便捷的、可容忍的、安全的药物。公司有其专有办法，结合化学和生物学，利用其在多价方面的知识，发现新的候选产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.008814},{"month":2,"riseRate":0.454545,"avgChangeRate":0.033911},{"month":3,"riseRate":0.636364,"avgChangeRate":0.011078},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.018235},{"month":5,"riseRate":0.545455,"avgChangeRate":0.015297},{"month":6,"riseRate":0.545455,"avgChangeRate":0.001722},{"month":7,"riseRate":0.545455,"avgChangeRate":0.015841},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.015489},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.022273},{"month":10,"riseRate":0.454545,"avgChangeRate":0.001706},{"month":11,"riseRate":0.6,"avgChangeRate":0.071834},{"month":12,"riseRate":0.7,"avgChangeRate":0.034006}],"exchange":"NASDAQ","name":"Innoviva, Inc.","nameEN":"Innoviva"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Innoviva, Inc.(INVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Innoviva, Inc.(INVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Innoviva, Inc.,INVA,Innoviva, Inc.股票,Innoviva, Inc.股票老虎,Innoviva, Inc.股票老虎国际,Innoviva, Inc.行情,Innoviva, Inc.股票行情,Innoviva, Inc.股价,Innoviva, Inc.股市,Innoviva, Inc.股票价格,Innoviva, Inc.股票交易,Innoviva, Inc.股票购买,Innoviva, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Innoviva, Inc.(INVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Innoviva, Inc.(INVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}